Imdur and Escherichia infection - a phase IV clinical study of FDA data

Summary:

Escherichia infection is found among people who take Imdur, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Imdur and have Escherichia infection. It is created by eHealthMe based on reports of 16,382 people who have side effects when taking Imdur from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 25, 2022

16,382 people reported to have side effects when taking Imdur.
Among them, 24 people (0.15%) have Escherichia infection.


What is Imdur?

Imdur has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 16,616 Imdur users for its effectiveness, alternative drugs and more.

What is Escherichia infection?

Escherichia infection (bacterial infection by escherichia coli) is found to be associated with 1,330 drugs and 801 conditions by eHealthMe.

Number of Imdur and Escherichia infection reports submitted per year:

Could Imdur cause Escherichia infection?

Gender of people who have Escherichia infection when taking Imdur *:

  • female: 50 %
  • male: 50 %

Age of people who have Escherichia infection when taking Imdur *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 14.29 %
  • 60+: 85.71 %

Common drugs people take besides Imdur *:

  1. Lipitor: 11 people, 45.83%
  2. Lasix: 9 people, 37.50%
  3. Lisinopril: 8 people, 33.33%
  4. Prednisone: 8 people, 33.33%
  5. Norvasc: 8 people, 33.33%
  6. Plavix: 7 people, 29.17%
  7. Synthroid: 7 people, 29.17%
  8. Lantus: 6 people, 25.00%
  9. Prilosec: 6 people, 25.00%
  10. Humalog: 5 people, 20.83%

Common side effects people have besides Escherichia infection *:

  1. Urinary Tract Infection: 7 people, 29.17%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 29.17%
  3. Acute Kidney Failure: 6 people, 25.00%
  4. Renal Failure Acute (rapid kidney dysfunction): 6 people, 25.00%
  5. Hypotension (abnormally low blood pressure): 5 people, 20.83%
  6. Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 20.83%
  7. Cardiac Failure Congestive: 5 people, 20.83%
  8. Hepatic Failure (liver failure): 5 people, 20.83%
  9. Weight Decreased: 4 people, 16.67%
  10. General Physical Health Deterioration (weak health status): 4 people, 16.67%

Common conditions people have *:

  1. Type 2 Diabetes: 4 people, 16.67%
  2. Essential Hypertension (primary hypertension): 4 people, 16.67%
  3. Dyslipidaemia (abnormal amount of lipids): 4 people, 16.67%
  4. Cardiac Failure Congestive: 4 people, 16.67%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 12.50%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 8.33%
  7. Pain In Extremity: 1 person, 4.17%
  8. Osteoporosis (bones weak and more likely to break): 1 person, 4.17%
  9. Hot Flush (sudden feelings of heat): 1 person, 4.17%
  10. Gastric Disorder (disease of stomach): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Imdur and have Escherichia infection?

Check whether Escherichia infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Escherichia infection and when was it recovered:

Expand to all the drugs that have ingredients of isosorbide mononitrate:

Alternative drugs to, pros and cons of Imdur:

Common Imdur side effects:

Browse all side effects of Imdur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Escherichia infection treatments and more:

COVID vaccines that are related to Escherichia infection:

Common drugs associated with Escherichia infection:

All the drugs that are associated with Escherichia infection:

Common conditions associated with Escherichia infection:

All the conditions that are associated with Escherichia infection:

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate (the active ingredients of Imdur) and Imdur (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: